Marlene Daloyau

Title: Marlene Daloyau: Innovator in Nucleic Acid Research

Introduction

Marlene Daloyau is a prominent inventor based in Castanet, France. She has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid sequences and plasmids. With a total of 2 patents to her name, her work has implications for phage resistance mechanisms in bacteria.

Latest Patents

Marlene's latest patents include innovative inventions related to nucleic acid sequences. The first patent describes polynucleotides of 1345 bp and 3704 bp that comprise at least one phage resistance mechanism. These polynucleotides are obtainable from the total DNA contained in the Lactococcus lactis ssp cremoris strain deposited in the CNCM under No. I-941. The second patent focuses on a polynucleotide of 817 bp, which also includes at least one phage resistance mechanism and is obtainable from the same strain, deposited under No. I-943.

Career Highlights

Marlene is currently associated with Systems Bio Industries, where she continues to advance her research in molecular biology. Her work is crucial in understanding and developing solutions to combat phage infections in bacterial cultures.

Collaborations

Marlene collaborates with notable colleagues, including Fabien Prevots and Sandrine Tolou. These partnerships enhance her research efforts and contribute to the innovative environment at Systems Bio Industries.

Conclusion

Marlene Daloyau is a dedicated inventor whose work in nucleic acid research is paving the way for advancements in phage resistance. Her contributions are vital to the scientific community and hold promise for future innovations in biotechnology.